These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9101515)

  • 1. The syndrome of osteoarthritis.
    Altman RD
    J Rheumatol; 1997 Apr; 24(4):766-7. PubMed ID: 9101515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoarthritis.
    Mahajan A; Verma S; Tandon V
    J Assoc Physicians India; 2005 Jul; 53():634-41. PubMed ID: 16190135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoarthritis clinical trials: candidate variables and clinimetric properties.
    Bellamy N
    J Rheumatol; 1997 Apr; 24(4):768-78. PubMed ID: 9101516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoarthritis.
    Buckwalter JA; Martin JA
    Adv Drug Deliv Rev; 2006 May; 58(2):150-67. PubMed ID: 16530881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece. The ESORDIG study.
    Andrianakos AA; Kontelis LK; Karamitsos DG; Aslanidis SI; Georgountzos AI; Kaziolas GO; Pantelidou KV; Vafiadou EV; Dantis PC;
    J Rheumatol; 2006 Dec; 33(12):2507-13. PubMed ID: 17143985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
    Detora LM; Krupa D; Bolognese J; Sperling RS; Ehrich EW
    J Rheumatol; 2001 Nov; 28(11):2494-503. PubMed ID: 11708424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiopathogenesis of osteoarthritis.
    Brandt KD; Dieppe P; Radin EL
    Rheum Dis Clin North Am; 2008 Aug; 34(3):531-59. PubMed ID: 18687271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.
    Bellamy N; Kirwan J; Boers M; Brooks P; Strand V; Tugwell P; Altman R; Brandt K; Dougados M; Lequesne M
    J Rheumatol; 1997 Apr; 24(4):799-802. PubMed ID: 9101522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers in osteoarthritis.
    Rousseau JC; Delmas PD
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):346-56. PubMed ID: 17538566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular markers of osteoarthritis].
    Senolt L; Pavelka K
    Acta Chir Orthop Traumatol Cech; 2005; 72(3):191-6. PubMed ID: 16105504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint involvement patterns in nodal versus erosive osteoarthritis of the hands.
    Rovetta G; Monteforte P; Baratto L; Franchin F
    Int J Tissue React; 2004; 26(1-2):39-42. PubMed ID: 15573691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspectives on the clinical presentation of joint pain in human OA.
    Creamer P
    Novartis Found Symp; 2004; 260():64-74; discussion 74-8, 100-4, 277-9. PubMed ID: 15283444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs.
    Dougados M; Hawker G; Lohmander S; Davis AM; Dieppe P; Maillefert JF; Gossec L
    J Rheumatol; 2009 Sep; 36(9):2097-9. PubMed ID: 19738220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of patient characteristics on variability in pain and function over two years in early knee osteoarthritis.
    Paradowski PT; Englund M; Lohmander LS; Roos EM
    Health Qual Life Outcomes; 2005 Sep; 3():59. PubMed ID: 16188034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for symptomatic knee osteoarthritis fifteen to twenty-two years after meniscectomy.
    Englund M; Lohmander LS
    Arthritis Rheum; 2004 Sep; 50(9):2811-9. PubMed ID: 15457449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the role of molecular markers to monitor disease, intervention, and cartilage breakdown in osteoarthritis.
    Lohmander LS; Felson DT
    J Rheumatol; 1997 Apr; 24(4):782-5. PubMed ID: 9101518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiopathogenesis of osteoarthritis.
    Brandt KD; Dieppe P; Radin E
    Med Clin North Am; 2009 Jan; 93(1):1-24, xv. PubMed ID: 19059018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial joint degeneration and the syndrome of osteoarthritis.
    Buckwalter JA; Martin J; Mankin HJ
    Instr Course Lect; 2000; 49():481-9. PubMed ID: 10829201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Many paths converge in arthritis. Awareness of risk factors and illness mechanisms increase steadily].
    Lohmander S
    Lakartidningen; 2002 Nov; 99(45):4480-3. PubMed ID: 12469526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.
    Gossec L; Hawker G; Davis AM; Maillefert JF; Lohmander LS; Altman R; Cibere J; Conaghan PG; Hochberg MC; Jordan JM; Katz JN; March L; Mahomed N; Pavelka K; Roos EM; Suarez-Almazor ME; Zanoli G; Dougados M
    J Rheumatol; 2007 Jun; 34(6):1432-5. PubMed ID: 17552070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.